Quandt,D.; DieterZucht,H.; Amann,A.; Wulf-Goldenberg,A.; Borrebaeck,C.; Cannarile,M.; Lambrechts,D.; Oberacher,H.; Garrett,J.; Nayak,T.; Kazinski,M.; Massie,C.; Schwarzenbach,H.; Maio,M.; Prins,R.; Wendik,B.; Hockett,R.; Enderle,D.; Noerholm,M.; Hendriks,H.; Zwierzina,H.; Seliger,B.;
During the last decade, novel immunotherapeutic strategies, in particular antibodies directed against immune checkpoint inhibitors, have revolutionized the treatment of different malignancies leading to an improved survival of patients. Identification of immune-related biomarkers for diagnosis, prognosis, monitoring of immune responses and selection of patients for specific cancer immunotherapies is urgently required and therefore areas of intensive research.
[Read More]